Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
La Mesta is a French Contract Development and Manufacturing Organization (CDMO) specializing in the production of fine chemicals and active pharmaceutical ingredients (APIs). The company is a pioneer in continuous flow chemistry, utilizing its proprietary RAPHAEL technology to offer efficient, safe, and scalable manufacturing processes. Based in Gattières, France, La Mesta serves the pharmaceutical, cosmetic, and specialty chemical industries. In 2021, the company was acquired by the Servier Group to bolster its chemical production capabilities and integrate advanced flow chemistry techniques. Their expertise includes handling hazardous reactions such as phosgenation and ozonolysis under GMP conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on La Mesta Chimie.